@FrederickLangMD
Honored to receive the CNS Foundation CV Section Young Investigator Award for our work on endovascular cellular therapeutics for GBM @CNS_Update @cvsection @FrederickLangMD @PeterKa80460001 @s0schen @MDAndersonNews. Alongside fellowship mentor @DrRishengXu @HopkinsNsurgView quoted post on X
Delighted to share our latest research published in @Cancer_Cell Cell. Our study shows that intratumoral administration of IL-21 engineered NK cells resulted in strong and sustained antitumor activity against glioblastoma compared to IL-15 NK cells, which carried significant toxicity when administered intracranially in multiple orthotopic mouse models. We also discovered the critical role of the CEBP family of transcription factors, particularly CEBPD, in maintaining the potency of IL-21 NK cells. Congratulations to @Mayrashanley and many thanks to our collaborators. @FrederickLangMD, Juan Fueyo MD, Cande Gomez-Manzano MD, @abhinavjain_phd, @kchenken. Looking forward to taking this to the clinic! authors.elsevier.com/a/1jar95TA51hO… #CancerResearch #Glioblastoma #NK #immunotherapy #cytokines #IL21View quoted post on X
Congratulations @ChrisYoungNSG . Blood brain barrier opening will be critical to IA biologic agents delivery to brain cancer @FrederickLangMD @s0schenView quoted post on X
The Elias family has long supported MD Anderson’s research.View quoted post on X
“Now is the time for us to increase our commitment,” says Howard Elias of their latest $16.25 million gift to advance brain tumor and cancer neuroscience research. bit.ly/3XTTXj7 #glioblastoma #EndCancer
Humbled & honored to be named one of the awardees of @theABTA fellowship grant & excited to continue our work to #endcancer #GBM
@BettyKimlab @wenjiang @mdandersonnews @NSTumorSection bit.ly/2022ABTAGrantsView quoted post on X
